FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Schrappe

Research Profile

Disorders

Living Beings

Infants

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Cornelia Eckert; Gabriele Escherich; Tom W L Groeneveld; Thomas Klingebiel; Christina Peters; Martin Schrappe; Karl Seeger; Arend von Stackelberg; Arndt Borkhardt; Günter Henze
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
Carmelo Rizzari; Antonella Colombini; Valentino Conter; Anja Moericke; Jan Starý; Martin Schrappe
Optimizing asparaginase therapy for acute lymphoblastic leukemia.
Jana Volejnikova; Olga Zimmermannova; Gunnar Cario; Petra Dörge; Ondrej Hrusak; Barbara Meissner; Ester Mejstrikova; Martin Schrappe; Martin Stanulla; Jan Stary; Karel Svojgr; Jan Trka; Eva Fronkova
Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Schrappe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cornelia Eckert; Gabriele Escherich; Tom W L Groeneveld; Thomas Klingebiel; Christina Peters; Martin Schrappe; Karl Seeger; Arend von Stackelberg; Arndt Borkhardt; Günter Henze
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
European journal of cancer (Oxford, England : 1990) 2013;49(6):1346-55.
2013: Carmelo Rizzari; Antonella Colombini; Valentino Conter; Anja Moericke; Jan Starý; Martin Schrappe
Optimizing asparaginase therapy for acute lymphoblastic leukemia.
Current opinion in oncology 2013;25 Suppl 1():S1-9.
2013: Jana Volejnikova; Olga Zimmermannova; Gunnar Cario; Petra Dörge; Ondrej Hrusak; Barbara Meissner; Ester Mejstrikova; Martin Schrappe; Martin Stanulla; Jan Stary; Karel Svojgr; Jan Trka; Eva Fronkova
Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Pediatric blood & cancer 2013;60(3):420-7.
2013: Petra Dörge; Jochen Harbott; Rolf Koehler; Wolf-Dieter Ludwig; Barbara Meissner; Anja Möricke; Richard Ratei; Denis Schewe; Martin Schrappe; André Schrauder; Martin Stanulla; Andrea Teigler-Schlegel; Martin Zimmermann; Claus R Bartram; Jean-Pierre Bouquin; Gunnar Cario
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Haematologica 2013;98(3):428-32.
2013: Stephen P Hunger; Sima Jeha; Mignon Loh; Anja Moericke; Rob Pieters; Mary V Relling; Kjeld Schmiegelow; Martin Schrappe; Lewis B Silverman; Martin Stanulla; Maria Grazia Valsecchi; Ajay Vora; Andre Baruchel; Andrea Biondi; William E Evans; Ching-Hon Pui
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011.
Pediatric blood & cancer 2013;60(2):344-8.
2013: Klaus Rehe; Martin Schrappe; Martin Stanulla; Simon Bomken; Monique L den Boer; Andrew G Hall; Olaf Heidenreich; Julie Irving; Daniel Williamson; Kerrie Wilson; Josef Vormoor
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations.
EMBO molecular medicine 2013;5(1):38-51.
2012: Franco Locatelli; Maria Ester Bernardo; Martin Schrappe; Sergio Rutella
How I treat relapsed childhood acute lymphoblastic leukemia.
Blood 2012;120(14):2807-16.
2012: Claus R Bartram; Rolf Köhler; André Schrauder; Martin Schrappe
Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment.
Deutsches Ärzteblatt international 2012;109(40):652-8.
2012: Giuseppe Gaipa; Leonid Karawajew; Wolf-Dieter Ludwig; Oscar Maglia; Renate Panzer-Grümayer; Richard Ratei; Simona Sala; Martin Schrappe; André Schrauder; Angela Schumich; Daniela Silvestri; Maria Grazia Valsecchi; Marinella Veltroni; Tiziana Villa; Alessandra Benetello; Andrea Biondi; Barbara Buldini; Giovanni Cazzaniga; Valentino Conter; Michael Dworzak; Giuseppe Basso
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.
Haematologica 2012;97(10):1582-93.
2012: Chiara Palmi; Vincenzo Rossi; Martin Schrappe; C Shochat; Daniela Silvestri; Martin Stanulla; Maria Grazia Valsecchi; E Vendramini; T Villa; Giuseppe Basso; Andrea Biondi; Gunnar Cario; Giovanni Cazzaniga; Valentino Conter; A M Di Meglio; Grazia Fazio; D Frison; Emanuela Giarin; Shai Izraeli; Anna Leszl; G Longinotti; Geertruy Te Kronnie
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia.
Leukemia 2012;26(10):2245-53.
2012: Andrea Biondi; Myriam Campbell; Anders Castor; Paola De Lorenzo; Gabriele Escherich; Virginie Gandemer; Chi-Kong Li; Giovanna Lucchini; Rob Pieters; Silja Röttgers; Vaskar Saha; Martin Schrappe; Jan Stary; Maurizio Aricò; Ajay Vora; Maria Grazia Valsecchi
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
The lancet oncology 2012;13(9):936-45.
2012: Andishe Attarbaschi; Jutta Bradtke; Gunnar Cario; Giovanni Cazzaniga; Valentino Conter; Hannah M Ensor; Oskar A Haas; Christine J Harrison; Georg Mann; Christopher D Mitchell; Anthony V Moorman; Maria Morak; Chiara Palmi; Renate Panzer-Grümayer; Ulrike Pötschger; Lisa J Russell; Martin Schrappe; Claire Schwab; Martin Stanulla; Sabine Strehl; Truus te Kronnie; Elena Vendramini; Martin Zimmermann
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups.
British journal of haematology 2012;158(6):772-7.
2012: Melchior Lauten; Barbara Meissner; Anja Möricke; Charlotte Niemeyer; Felix Niggli; Edelgard Odenwald; Hansjörg Riehm; Andishe Attarbaschi; Rita Beier; Martin Stanulla; Martin Zimmermann; Martin Schrappe
Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Haematologica 2012;97(7):1048-56.
2012: E Ellinghaus; Abdou ElSharawy; C Franceschi; T Bartram; Gunnar Cario; H Cavé; Giovanni Cazzaniga; Ondrej Cinek; D Ellinghaus; M Giordan; Robert Häsler; B Heinzow; M Horstmann; Francesco Lescai; Barbara Meissner; Almut Nebel; Peter Nürnberg; R Panzer Grümayer; G Richter; Martin Schrappe; Stefan Schreiber; Martin Stanulla; Geertruy Te Kronnie; Andrea Teigler-Schlegel; Jan Trka; Martin Zimmermann; Andre Franke
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.
Leukemia 2012;26(5):902-9.
2012: Martin Schrappe; Lewis B Silverman; Anne Birgitta Versluys; André Baruchel; Bruce M Camitta; Valentino Conter; Meenakshi Devidas; Gabriele Escherich; Paul S Gaynon; Jochen Harbott; Mats Heyman; Keizo Horibe; Stephen P Hunger; Georg Mann; Akira Ohara; Jacques Otten; Ching-Hon Pui; Sue Richards; Hansjörg Riehm; Vaskar Saha; Martin Zimmermann
Outcomes after induction failure in childhood acute lymphoblastic leukemia.
The New England journal of medicine 2012;366(15):1371-81.
2012: Lutz Zeidler; Martin Zimmermann; Andrea Teigler-Schlegel; Christoph Tschan; Karl Welte; Dorothee Bartels; Claus R Bartram; Gunnar Cario; Lilia Goudeva; Sarah Jäger; Rolf Koehler; Wolf-Dieter Ludwig; Barbara Meissner; Anja Möricke; Richard Ratei; Hansjörg Riehm; Martin Schrappe; André Schrauder; Julia Skokowa; Martin Stanulla
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Haematologica 2012;97(3):402-9.
2012: Martin Schrappe
Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2012;2012():137-42.
2011: Klaus Bienemann; Kirsten Bienemann; Birgit Burkhardt; Gabriele Escherich; Gritta E Janka-Schaub; Dieter Körholz; Christine Mauz-Körholz; Ulrike Meyer; Simon Modlich; Anja Möricke; Alfred Reiter; Martin Schrappe; Martin Zimmermann; Arndt Borkhardt
Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.
British journal of haematology 2011;155(4):468-76.
2011: Daniel Steinbach; Brigitte Strahm; Arend von Stackelberg; Bernhard Wilhelm; Martin Zimmermann; Ursula Creutzig; Klaus-Michael Debatin; Bernd Gruhn; Heribert Jürgens; Hans-Rudolf Kiermaier; Dirk Reinhardt; Martin Schrappe; Anja Möricke
Long term survival in children with acute leukaemia and complications requiring mechanical ventilation.
Archives of disease in childhood 2011;96(11):1026-32.
2011: Seisho Takeuchi; Martin Zimmermann; Claus R Bartram; Takayuki Ikezoe; Naoki Komatsu; Masahide Matsushita; Martin Schrappe; Taku Seriu; H Phillip Koeffler
Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.
Leukemia research 2011;35(10):1345-9.
2011: Martin Schrappe; André Schrauder; Maria Grazia Valsecchi; Jacques J M van Dongen; Karl Welte; Martin Zimmermann; Maurizio Aricò; Claus R Bartram; Giuseppe Basso; Andrea Biondi; Barbara Buldini; Giovanni Cazzaniga; Michael Dworzak; Helmut Gadner; Thomas Klingebiel; Rolf Koehler; Franco Locatelli; Chiara Messina; Anja Möricke; Renate Panzer-Grümayer; Rosanna Parasole; Richard Ratei; Alfred Reiter; Beat W Schäfer; Valentino Conter
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Blood 2011;118(8):2077-84.
2011: Maike Schmitz; Martin Schrappe; André Schrauder; Martin Stanulla; Joelle Tchinda; Petra Breithaupt; Gunnar Cario; Barbara Meissner; Paulina Mirkowska; Felix K Niggli; Nastassja Scheidegger; Laura Bonapace; Beat Bornhauser; Jean-Pierre Bourquin
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment.
Blood 2011;118(7):1854-64.
2011: Cornelia Eckert; T Flohr; N Hagedorn; Günter Henze; Renate Kirschner-Schwabe; R Koehler; A Moericke; Martin Schrappe; Claus R Bartram; G Cario; Av Stackelberg; Martin Stanulla; André Schrauder
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment.
Leukemia 2011;25(8):1305-13.
2011: Chen Shochat; Noa Tal; Obul R Bandapalli; Chiara Palmi; Ithamar Ganmore; Geertruy Te Kronnie; Gunnar Cario; Giovanni Cazzaniga; Andreas E Kulozik; Martin Stanulla; Martin Schrappe; Andrea Biondi; Giuseppe Basso; Dani Bercovich; Martina U Muckenthaler; Shai Izraeli
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.
The Journal of experimental medicine 2011;208(5):901-8.
2011: Lüder Hinrich Meyer; Sarah Mirjam Eckhoff; Manon Queudeville; Johann Michael Kraus; Marco Giordan; Jana Stursberg; Andrea Zangrando; Elena Vendramini; Anja Möricke; Martin Zimmermann; Andre Schrauder; G Lahr; Karlheinz Holzmann; Martin Schrappe; Giuseppe Basso; Karsten Stahnke; Hans Armin Kestler; Geertruy Te Kronnie; Klaus-Michael Debatin
Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways.
Cancer cell 2011;19(2):206-17.
2011: Rob Pieters; Stephen P Hunger; Joachim Boos; Carmelo Rizzari; Lewis Silverman; Andre Baruchel; Nicola Goekbuget; Martin Schrappe; Ching-Hon Pui
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.
Cancer 2011;117(2):238-49.
2011: Thorsten Simon; Barbara Hero; Andreas Faldum; Rupert Handgretinger; Martin Schrappe; Thomas Klingebiel; Frank Berthold
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy.
BMC cancer 2011;11():21.
2011: Birgit Burkhardt; Ilske Oschlies; Wolfram Klapper; Martin Zimmermann; Willi Woessmann; A Meinhardt; Eva Landmann; Andishe Attarbaschi; Felix Niggli; Martin Schrappe; Alfred Reiter
Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
Leukemia 2011;25(1):153-60.
2010: Martin Schrappe
Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial.
Lancet 2010;376(9757):1968-70.
2010: C Kox; M Zimmermann; Martin Stanulla; S Leible; Martin Schrappe; Wolf-Dieter Ludwig; R Koehler; G Tolle; Obul Reddy Bandapalli; Stephen Breit; Martina U Muckenthaler; Andreas E Kulozik
The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
Leukemia 2010;24(12):2005-13.
2010: Maurizio Aricò; Martin Schrappe; Stephen P Hunger; William L Carroll; Valentino Conter; Stefania Galimberti; Atsushi Manabe; Vaskar Saha; André Baruchel; Kim Vettenranta; Keizo Horibe; Yves Benoit; Rob Pieters; Gabriele Escherich; Lewis B Silverman; Ching-Hon Pui; Maria Grazia Valsecchi
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4755-61.
2010: Georg Mann; Andishe Attarbaschi; Martin Schrappe; Paola De Lorenzo; Christina Peters; Ian Hann; Giulio De Rossi; Maria Felice; Birgitte Lausen; Thierry Leblanc; Tomasz Szczepanski; Alina Ferster; Gritta Janka-Schaub; Jeffrey Rubnitz; Lewis B Silverman; Jan Stary; Myriam Campbell; Chi Kong Li; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi; Rob Pieters
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.
Blood 2010;116(15):2644-50.
2010: B Dresske; Maren Schulze; Felix Braun; J Walter; M Kohl; S Schulz-Jürgensen; M Krause; Martin Schrappe; M Burdelski; D C Bröring
[Living donation liver transplantation in children].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2010;81(9):813-9.
2010: Andrea Meinhardt; Birgit Burkhardt; Martin Zimmermann; Arndt Borkhardt; Udo Kontny; Thomas Klingebiel; Frank Berthold; Gritta Janka-Schaub; Christoph Klein; Edita Kabickova; Wolfram Klapper; Andishe Attarbaschi; Martin Schrappe; Alfred Reiter
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(19):3115-21.
2010: Gunnar Cario; Martin Zimmermann; Renja Romey; Stefan Gesk; Inga Vater; Jochen Harbott; André Schrauder; Anja Moericke; Shai Izraeli; Takashi Akasaka; Martin J S Dyer; Reiner Siebert; Martin Schrappe; Martin Stanulla
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol.
Blood 2010;115(26):5393-7.
2010: Dominik Schrey; Stephan Borghorst; Claudia Lanvers-Kaminsky; Georg Hempel; Joachim Gerss; Anja Möricke; Martin Schrappe; Joachim Boos
Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.
Pediatric blood & cancer 2010;54(7):952-8.
2010: Gesche Tallen; Richard Ratei; Georg Mann; Gertjan Kaspers; Felix Niggli; Alexandr Karachunsky; Wolfram Ebell; Gabriele Escherich; Martin Schrappe; Thomas Klingebiel; Ruediger Fengler; Günter Henze; Arend von Stackelberg
Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2339-47.
2010: Peter Rhein; Rita Mitlohner; Giuseppe Basso; Giuseppe Gaipa; Michael N Dworzak; Renate Kirschner-Schwabe; Christian Hagemeier; Martin Stanulla; Martin Schrappe; Wolf-Dieter Ludwig; Leonid Karawajew; Richard Ratei
CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia.
Blood 2010;115(18):3763-71.
2010: Petra Gastmeier; Frank M Brunkhorst; Martin Schrappe; W Kern; Christine Geffers
[How many nosocomial infections are avoidable?].
Deutsche medizinische Wochenschrift (1946) 2010;135(3):91-3.
2010: Laura Bonapace; Beat C Bornhauser; Maike Schmitz; Gunnar Cario; Urs Ziegler; Felix K Niggli; Beat W Schäfer; Martin Schrappe; Martin Stanulla; Jean-Pierre Bourquin
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.
The Journal of clinical investigation 2010;120(4):1310-23.
2010: Heidrun Gerr; Martin Zimmermann; Martin Schrappe; Michael Dworzak; Wolf-Dieter Ludwig; Jutta Bradtke; Anja Moericke; Richard Schabath; Ursula Creutzig; Dirk Reinhardt
Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations.
British journal of haematology 2010;149(1):84-92.
2010: Herbert Pichler; Anja Möricke; Georg Mann; Andrea Teigler-Schlegel; Felix Niggli; Karin Nebral; Margit König; Andrea Inthal; Daniela Krehan; Michael Dworzak; Dasa Janousek; Jochen Harbott; Martin Schrappe; Helmut Gadner; Sabine Strehl; Oskar A Haas; Renate Panzer-Grümayer; Andishe Attarbaschi
Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
British journal of haematology 2010;149(1):93-100.
2010: Rashmi Prasad; Fay J Hosking; Jayaram Vijayakrishnan; Elli Papaemmanuil; Rolf Koehler; Mel Greaves; Eamonn Sheridan; Andreas Gast; Sally E Kinsey; Tracy Lightfoot; Eve Roman; Malcolm Taylor; Kathy Pritchard-Jones; Martin Stanulla; Martin Schrappe; Claus R Bartram; Richard S Houlston; Rajiv Kumar; Kari Hemminki
Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.
Blood 2010;115(9):1765-7.
2010: Anja Möricke; Martin Zimmermann; Alfred Reiter; Günter Henze; André Schrauder; Helmut Gadner; Wolf-Dieter Ludwig; J Ritter; Jochen Harbott; Georg Mann; Thomas Klingebiel; Felix Zintl; C Niemeyer; Bernhard Kremens; Felix Niggli; Dietrich Niethammer; Karl Welte; Martin Stanulla; E Odenwald; Hansjörg Riehm; Martin Schrappe
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
Leukemia 2010;24(2):265-84.
2010: Andishe Attarbaschi; Markus Pisecker; Andrea Inthal; Georg Mann; Dasa Janousek; Michael Dworzak; Ulrike Pötschger; Reinhard Ullmann; Martin Schrappe; Helmut Gadner; Oskar A Haas; Renate Panzer-Grümayer; Sabine Strehl
Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
British journal of haematology 2010;148(2):293-300.
2010: Ester Mejstríková; Eva Fronková; Tomás Kalina; Marek Omelka; Drago Batinić; Klara Dubravcić; Klára Pospísilová; Martina Vásková; Drorit Luria; Suk-Hang Cheng; Margaret Ng; Yonna Leung; Janos Kappelmayer; Flora Kiss; Shai Izraeli; Batia Stark; Martin Schrappe; Jan Trka; Jan Starý; Ondrej Hrusák
Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
Pediatric blood & cancer 2010;54(1):62-70.
2010: David Krieger; Anja Moericke; Ilske Oschlies; Martin Zimmermann; Martin Schrappe; Alfred Reiter; Birgit Burkhardt
Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia.
Haematologica 2010;95(1):158-62.
2009: Stephen E Sallan; Martin Schrappe; Lewis B Silverman
Treating childhood leukemia without cranial irradiation.
The New England journal of medicine 2009;361(13):1310; author reply 1311-2.
2009: Arne Kristian Schwarz; Martin Stanulla; Gunnar Cario; Thomas Flohr; Rosemary Sutton; Anja Möricke; Philippe Anker; Maurice Stroun; Karl Welte; Claus R Bartram; Martin Schrappe; André Schrauder
Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
Annals of hematology 2009;88(9):897-905.
2009: Martin Stanulla; Elke Schaeffeler; Anja Möricke; Sally A Coulthard; Gunnar Cario; André Schrauder; Peter Kaatsch; Michael Dördelmann; Karl Welte; Martin Zimmermann; Alfred Reiter; Michel Eichelbaum; Hansjörg Riehm; Martin Schrappe; Matthias Schwab
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
Blood 2009;114(7):1314-8.
2009: Marc Remke; Stefan Pfister; Corinne Kox; Grischa Toedt; N Becker; Axel Benner; Wiebke Werft; Stephen Breit; Shuangyou Liu; Felix Engel; Andrea Wittmann; Martin Zimmermann; Martin Stanulla; Martin Schrappe; Wolf-Dieter Ludwig; Claus R Bartram; Bernhard Radlwimmer; Martina U Muckenthaler; Peter Lichter; Andreas E Kulozik
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response.
Blood 2009;114(5):1053-62.
2009: C Reichardt; Maria Eberlein-Gonska; Martin Schrappe; Petra Gastmeier
[Clean Hands Campaign. No chance for hospital infections!].
Der Unfallchirurg 2009;112(7):679-82.
2009: Liping Dai; Andreas Gast; Alexandra Horska; Martin Schrappe; Claus R Bartram; Kari Hemminki; Rajiv Kumar; Justo Lorenzo Bermejo
A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes.
Pediatric blood & cancer 2009;52(7):819-23.
2009: Norihiko Kawamata; Seishi Ogawa; Karl Seeger; Renate Kirschner-Schwabe; Thien Huynh; John Chen; Nairi Megrabian; Jochen Harbott; Martin Zimmermann; Günter Henze; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
International journal of oncology 2009;34(6):1603-12.
2009: Ekaterini Kidas; Anja Möricke; Rita Beier; Karl Welte; Martin Schrappe; Martin Stanulla; Lorenz Grigull
Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study.
International journal of hematology 2009;89(5):584-91.
2009: V H J van der Velden; L Corral; Maria Grazia Valsecchi; M W J C Jansen; Paola de Lorenzo; Giovanni Cazzaniga; E Renate Panzer-Grümayer; Martin Schrappe; André Schrauder; Claus Meyer; Rolf Marschalek; L L Nigro; M Metzler; G Basso; G Mann; Monique L den Boer; A Biondi; Rob Pieters; J J M Van Dongen
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.
Leukemia 2009;23(6):1073-9.
2009: Gudmar Lönnerholm; Maria Grazia Valsecchi; Paola De Lorenzo; Martin Schrappe; Liisa Hovi; Myriam Campbell; Georg Mann; Gritta Janka-Schaub; Chi kong Li; Jan Stary; Ian Hann; Rob Pieters
Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia.
Pediatric blood & cancer 2009;52(5):596-601.
2009: Melchior Lauten; Ivonne Fernandez-Munoz; Katrin Gerdes; Nils von neuhoff; Karl Welte; Brigitte Schlegelberger; Martin Schrappe; Carmela Beger
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
Pediatric blood & cancer 2009;52(4):459-63.
2009: Richard Ratei; G Basso; M Dworzak; G Gaipa; M Veltroni; Peter Rhein; A Biondi; Martin Schrappe; Wolf-Dieter Ludwig; Leonid Karawajew
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
Leukemia 2009;23(3):528-34.
2008: Oliver Teuffel; Martin Stanulla; Gunnar Cario; Wolf D Ludwig; Silja Rottgers; Beat W Schafer; Martin Zimmermann; Martin Schrappe; Felix K Niggli
Anemia and survival in childhood acute lymphoblastic leukemia.
Haematologica 2008;93(11):1652-7.
2008: Dani Bercovich; Ithamar Ganmore; Linda Maree SCOTT; Gilad Wainreb; Yehudit Birger; Arava Elimelech; Chen Shochat; Giovanni Cazzaniga; Andrea Biondi; Giuseppe Basso; Gunnar Cario; Martin Schrappe; Martin Stanulla; Sabine Strehl; Oskar A Haas; Georg Mann; Vera Binder; Arndt Borkhardt; Helena Kempski; Jan Trka; Bella Bielorei; Smadar Avigad; Batia Stark; Owen Smith; Nicole Dastugue; Jean-Pierre Bourquin; Nir Ben Tal; Anthony R Green; Shai Izraeli
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Lancet 2008;372(9648):1484-92.
2008: Gunnar Cario; Andrea Fetz; Christian Bretscher; Anja Möricke; André Schrauder; Martin Stanulla; Martin Schrappe
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Annals of hematology 2008;87(9):709-16.
2008: Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Birte Niebuhr; Carol Stocking; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(33):11921-6.
2008: Christoph le Viseur; Marc Hotfilder; Simon Bomken; Kerrie Wilson; Silja Röttgers; André Schrauder; Annegret Rosemann; Julie Irving; Ronald W Stam; Leonard D Shultz; Jochen Harbott; Heribert Jürgens; Martin Schrappe; Rob Pieters; Josef Vormoor
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
Cancer cell 2008;14(1):47-58.
2008: Andishe Attarbaschi; Georg Mann; Renate Panzer-Grümayer; Silja Röttgers; Manuel Steiner; Margit König; Eva Csinady; Michael Dworzak; Markus Seidel; Dasa Janousek; Anja Möricke; Carsten Reichelt; Jochen Harbott; Martin Schrappe; Helmut Gadner; Oskar A Haas
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3046-50.
2008: André Schrauder; A von Stackelberg; Martin Schrappe; J Cornish; Christina Peters
Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials.
Bone marrow transplantation 2008;41 Suppl 2():S71-4.
2008: Adriana Balduzzi; Paola de Lorenzo; André Schrauder; Valentino Conter; Cornelio Uderzo; Christina Peters; Thomas Klingebiel; Jan Stary; Maria S Felice; Edina Magyarosy; Martin Schrappe; Giorgio Dini; Helmut Gadner; Maria Grazia Valsecchi
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Haematologica 2008;93(6):925-9.
2008: Doris Steinemann; Gunnar Cario; Martin Stanulla; Leonid Karawajew; Marcel Tauscher; Anja Weigmann; Gudrun Göhring; Wolf-Dieter Ludwig; Jochen Harbott; Bernhard Radlwimmer; Claus Bartram; Peter Lichter; Martin Schrappe; Brigitte Schlegelberger
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Genes, chromosomes & cancer 2008;47(6):471-80.
2008: Eva Fronkova; Ester Mejstrikova; S Avigad; K W Chik; L Castillo; S Manor; L Reznickova; T Valova; K Zdrahalova; Ondrej Hrusak; Y Jabali; Martin Schrappe; Valentino Conter; S Izraeli; Chi kong Li; B Stark; Jan Stary; Jan Trka
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Leukemia 2008;22(5):989-97.
2008: Anja Möricke; Alfred Reiter; Martin Zimmermann; Helmut Gadner; Martin Stanulla; Michael Dördelmann; Lutz Löning; Rita Beier; Wolf-Dieter Ludwig; Richard Ratei; Jochen Harbott; Joachim Boos; Georg Mann; Felix Niggli; Andreas Feldges; Günter Henze; Karl Welte; Jörn D Beck; Thomas Klingebiel; Charlotte Niemeyer; Felix Zintl; Udo Bode; Christian Urban; Helmut Wehinger; Dietrich Niethammer; Hansjörg Riehm; Martin Schrappe
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
2008: T Flohr; André Schrauder; Giovanni Cazzaniga; R Panzer-Grümayer; V van der Velden; S Fischer; Martin Stanulla; G Basso; Felix Niggli; Beat W Schäfer; R Sutton; R Koehler; Martin Zimmermann; M G Valsecchi; Helmut Gadner; G Masera; Martin Schrappe; J J M van Dongen; A Biondi; C R Bartram
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
Leukemia 2008;22(4):771-82.
2008: Birgit Burkhardt; Anja Moericke; Wolfram Klapper; Franziska Greene; Janina Salzburg; Christine Damm-Welk; Martin Zimmermann; Konstantin Strauch; Wolf-Dieter Ludwig; Martin Schrappe; Alfred Reiter
Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
Leukemia & lymphoma 2008;49(3):451-61.
2008: Norihiko Kawamata; Seishi Ogawa; Martin Zimmermann; Motohiro Kato; Masashi Sanada; Kari Hemminki; Go Yamatomo; Yasuhito Nannya; Rolf Koehler; Thomas Flohr; Carl W Miller; Jochen Harbott; Wolf-Dieter Ludwig; Martin Stanulla; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
Blood 2008;111(2):776-84.
2008: Martin Schrappe
Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.
Radiation protection dosimetry 2008;132(2):130-3.
2007: Martin Stanulla; Christian Dynybil; Dorothee Bartels; Michael Dördelmann; Lutz Löning; Alexander Claviez; Martin Schrappe
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
Haematologica 2007;92(11):1581-2.
2007: Leo Kager; Thomas Lion; Andishe Attarbaschi; Margit Koenig; Sabine Strehl; Oskar A Haas; Michael Dworzak; Martin Schrappe; Helmut Gadner; Georg Mann
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
Haematologica 2007;92(11):1561-4.
2007: Georg Mann; Andishe Attarbaschi; Birgit Burkhardt; Felix Niggli; Wolfram Klapper; Wolf-Dieter Ludwig; Martin Schrappe; Martin Zimmermann; Helmut Gadner; Alfred Reiter
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
British journal of haematology 2007;139(3):443-9.
2007: Gunnar Cario; Shai Izraeli; Anja Teichert; Peter Rhein; Julia Skokowa; Anja Möricke; Martin Zimmermann; André Schrauder; Leonid Karawajew; Wolf-Dieter Ludwig; Karl Welte; Holger J Schünemann; Brigitte Schlegelberger; Martin Schrappe; Martin Stanulla
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4813-20.
2007: Beat Bornhauser; Laura Bonapace; Dan Lindholm; Rodrigo Martinez; Gunnar Cario; Martin Schrappe; Felix K Niggli; Beat W Schäfer; Jean-Pierre Bourquin
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Blood 2007;110(6):2084-91.
2007: Janina Salzburg; Birgit Burkhardt; Martin Zimmermann; Olga Wachowski; Willi Woessmann; Ilske Oschlies; Wolfram Klapper; Hans-Heinrich Wacker; Wolf-Dieter Ludwig; Felix Niggli; Georg Mann; Helmut Gadner; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3915-22.
2007: Martin Stanulla; Gunnar Cario; Barbara Meissner; André Schrauder; Anja Möricke; Hansjörg Riehm; Martin Schrappe
Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
Blood cells, molecules & diseases 2007;39(2):160-3.
2007: James B Nachman; Nyla A Heerema; Harland Sather; Bruce M Camitta; Erik Forestier; Christine J Harrison; Nicole Dastugue; Martin Schrappe; Ching-Hon Pui; Giuseppe Basso; Lewis B Silverman; Gritta E Janka-Schaub
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
Blood 2007;110(4):1112-5.
2007: Rob Pieters; Martin Schrappe; Paola de Lorenzo; Ian Hann; Giulio De Rossi; Maria Felice; Liisa Hovi; Thierry Leblanc; Tomasz Szczepanski; Alina Ferster; Gritta Janka; Jeffrey E Rubnitz; Lewis Silverman; Jan Stary; Myriam Campbell; Chi kong Li; Georg Mann; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
Lancet 2007;370(9583):240-50.
2007: Peter Rhein; Stefanie Scheid; Richard Ratei; Christian Hagemeier; Karl Seeger; Renate Kirschner-Schwabe; A Moericke; Martin Schrappe; Rainer Spang; Wolf-Dieter Ludwig; Leonid Karawajew
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
Leukemia 2007;21(5):897-905.
2007: André Schrauder; Cornelia Henke-Gendo; Kathrin Seidemann; Michael Sasse; Gunnar Cario; Anja Moericke; Martin Schrappe; Albert Heim; Armin Wessel
Varicella vaccination in a child with acute lymphoblastic leukaemia.
Lancet 2007;369(9568):1232.
2007: V H J van der Velden; E Renate Panzer-Grümayer; Giovanni Cazzaniga; T Flohr; R Sutton; André Schrauder; G Basso; Martin Schrappe; JM Wijkhuijs; M Konrad; C R Bartram; Guiseppe Masera; A Biondi; Jacques J M van Dongen
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.
Leukemia 2007;21(4):706-13.
2007: M W J C Jansen; L Corral; V H J van der Velden; R Panzer-Grümayer; Martin Schrappe; André Schrauder; Rolf Marschalek; Claus Meyer; Monique L den Boer; W J C Hop; Maria Grazia Valsecchi; G Basso; A Biondi; Rob Pieters; Jacques J M van Dongen
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
Leukemia 2007;21(4):633-41.
2007: Paul Krappmann; Marios Paulides; Wolfgang Stöhr; Edith Ittner; Bernhard Plattig; Petra Nickel; Herwig Lackner; Martin Schrappe; Gritta Janka; Jörn D Beck; Thorsten Langer
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Pediatric hematology and oncology 2007;24(2):101-9.
2007: Valentino Conter; Maria Grazia Valsecchi; Daniela Silvestri; Myriam Campbell; Eduardo Dibar; Edina Magyarosy; Helmut Gadner; Jan Stary; Yves Benoit; Martin Zimmermann; Alfred Reiter; Hansjörg Riehm; Giuseppe Masera; Martin Schrappe
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
Lancet 2007;369(9556):123-31.
2006: André Schrauder; Alfred Reiter; Helmut Gadner; Dietrich Niethammer; Thomas Klingebiel; Bernhard Kremens; Christina Peters; Wolfram Ebell; Martin Zimmermann; Felix Niggli; Wolf-Dieter Ludwig; Hansjörg Riehm; Karl Welte; Martin Schrappe
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5742-9.
2006: Stephen Breit; Martin Stanulla; Thomas Flohr; Martin Schrappe; Wolf-Dieter Ludwig; Gabriele Tolle; Margit Happich; Martina U Muckenthaler; Andreas E Kulozik
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
Blood 2006;108(4):1151-7.
2006: Frank Staal; Gunnar Cario; Giovanni Cazzaniga; T Haferlach; Michael Heuser; W-K Hofmann; K Mills; Martin Schrappe; Martin Stanulla; Luzie U Wingen; Jacques J M van Dongen; Brigitte Schlegelberger
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.
Leukemia 2006;20(8):1385-92.
2006: Lüder Hinrich Meyer; Leonid Karawajew; Martin Schrappe; Wolf-Dieter Ludwig; Klaus-Michael Debatin; Karsten Stahnke
Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL.
Blood 2006;107(11):4524-31.
2006: J Neudenberger; Marc Hotfilder; Annegret Rosemann; Claudia Langebrake; Dirk Reinhardt; Rob Pieters; André Schrauder; Martin Schrappe; Silja Röttgers; Jochen Harbott; Josef Vormoor
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
British journal of haematology 2006;133(3):337-44.
2006: Markus Metzler; Georg Mann; Uli Monschein; Martin Lodzinski; Christine Gall; Thomas Flohr; Susanne Viehmann; Thorsten Langer; Martin Schrappe; Helmut Gadner; Oskar A Haas; E Renate Panzer-Grümayer
Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene.
Haematologica 2006;91(5):683-6.
2006: Melchior Lauten; André Schrauder; Christian Kardinal; Jochen Harbott; Karl Welte; Brigitte Schlegelberger; Martin Schrappe; Nils von neuhoff
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Leukemia 2006;20(5):820-6.
2006: Britta Maecker; D Mougiakakos; Martin Zimmermann; M Behrens; S Hollander; André Schrauder; Martin Schrappe; Karl Welte; Christoph Klein
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
Leukemia 2006;20(4):645-9.
2006: Alexander Claviez; Cornelia Eckert; Karl Seeger; André Schrauder; Martin Schrappe; Günter Henze; Arend von Stackelberg
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Haematologica 2006;91(2):272-3.
2006: Birgit Burkhardt; Willi Woessmann; Martin Zimmermann; Udo Kontny; Josef Vormoor; Wolfgang Doerffel; Georg Mann; Günter Henze; Felix Niggli; Wolf-Dieter Ludwig; Dirk Janssen; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):491-9.
2006: H Gadner; Giuseppe Masera; Martin Schrappe; T Eden; Y Benoit; C Harrison; James B Nachman; Ching-Hon Pui
The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005.
Leukemia 2006;20(1):9-17.
2005: Anja Möricke; M Zimmermann; A Reiter; H Gadner; E Odenwald; Jochen Harbott; Wolf-Dieter Ludwig; Hansjörg Riehm; Martin Schrappe
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Klinische Pädiatrie 2005;217(6):310-20.
2005: Hagen Graf Einsiedel; Arend von Stackelberg; Reinhard Hartmann; Rüdiger Fengler; Martin Schrappe; Gritta E Janka-Schaub; Georg Mann; Karel Hählen; Ulrich Göbel; Thomas Klingebiel; Wolf-Dieter Ludwig; Günter Henze
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7942-50.
2005: Birgit Burkhardt; Martin Zimmermann; Ilske Oschlies; Felix Niggli; Georg Mann; Reza Parwaresch; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
British journal of haematology 2005;131(1):39-49.
2005: Frank Berthold; Joachim Boos; Stefan Burdach; Rudolf Erttmann; Günter Henze; Johann Hermann; Thomas Klingebiel; Bernhard Kremens; Freimut H Schilling; Martin Schrappe; Thorsten Simon; Barbara Hero
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
The lancet oncology 2005;6(9):649-58.
2005: Adriana Balduzzi; Maria Grazia Valsecchi; Cornelio Uderzo; Paola de Lorenzo; Thomas Klingebiel; Christina Peters; Jan Stary; Maria S Felice; Edina Magyarosy; Valentino Conter; Alfred Reiter; Chiara Messina; Helmut Gadner; Martin Schrappe
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Lancet 2005;366(9486):635-42.
2005: Oliver Teuffel; André Schrauder; Karl-Walter Sykora; M Zimmermann; A Reiter; Karl Welte; Martin Schrappe
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Bone marrow transplantation 2005;36(2):145-50.
2005: M Aricó; A Baruchel; Y Bertrand; Andrea Biondi; Valentino Conter; T Eden; H Gadner; P Gaynon; K Horibe; Stephen P Hunger; Gritta E Janka-Schaub; Giuseppe Masera; James B Nachman; R Pieters; Martin Schrappe; K Schmiegelow; Maria Grazia Valsecchi; Ching-Hon Pui
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005.
Leukemia 2005;19(7):1145-52.
2005: Eckart Schnakenberg; Andrea Mehles; Gunnar Cario; Klaus Rehe; Kathrin Seidemann; Brigitte Schlegelberger; Holger-Andreas Elsner; Karl H Welte; Martin Schrappe; Martin Stanulla
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
BMC medical genetics 2005;6():23.
2005: Thorsten Simon; Barbara Hero; Andreas Faldum; Rupert Handgretinger; Martin Schrappe; D Niethammer; Frank Berthold
Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14.18 consolidation therapy.
Klinische Pädiatrie 2005;217(3):147-52.
2005: Gunnar Cario; Julia Skokowa; Zheng Wang; Vesna Bucan; Cornelia Zeidler; Martin Stanulla; Martin Schrappe; Karl Welte
Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor.
British journal of haematology 2005;129(2):275-8.
2005: Anthony V Moorman; Susana C Raimondi; Ching-Hon Pui; A Baruchel; A Biondi; Andrew J Carroll; E Forestier; Paul S Gaynon; Jochen Harbott; Dieter Harms; Nyla A Heerema; R Pieters; Martin Schrappe; Lewis B Silverman; E Vilmer; Christine J Harrison
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
Leukemia 2005;19(4):557-63.
2005: Martin Stanulla; Elke Schaeffeler; Thomas Flohr; Gunnar Cario; André Schrauder; Martin Zimmermann; Karl Welte; Wolf-Dieter Ludwig; Claus R Bartram; Uli Zanger; Michel Eichelbaum; Martin Schrappe; Matthias Schwab
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
JAMA : the journal of the American Medical Association 2005;293(12):1485-9.
2005: Britta Bürger; Rita Beier; Martin Zimmermann; Jörn D Beck; Alfred Reiter; Martin Schrappe
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Pediatric blood & cancer 2005;44(3):220-5.
2005: Marc Hotfilder; Silja Röttgers; Annegret Rosemann; André Schrauder; Martin Schrappe; Rob Pieters; Heribert Jürgens; Jochen Harbott; Josef Vormoor
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Cancer research 2005;65(4):1442-9.
2005: Lorenz Grigull; Andreas Beilken; Martin Schrappe; A Das; T Luecke; Annette Sander; Martin Stanulla; Klaus Rehe; M Sauer; Hansjoerg Schmid; Karl Welte; Zoltan Lukacs; A Gal; Karl-Walter Sykora
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
Bone marrow transplantation 2005;35(3):265-9.
2005: Willi Woessmann; Kathrin Seidemann; Georg Mann; Martin Zimmermann; Birgit Burkhardt; Ilske Oschlies; Wolf-Dieter Ludwig; Thomas Klingebiel; Norbert Graf; Bernd Gruhn; Heribert Juergens; Felix Niggli; Reza Parwaresch; Helmut Gadner; Hansjörg Riehm; Martin Schrappe; Alfred Reiter
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Blood 2005;105(3):948-58.
2005: Martin Stanulla; Kathrin Seidemann; Eckart Schnakenberg; Marion Book; Andrea Mehles; Karl Welte; Martin Schrappe; Alfred Reiter
Methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population.
Blood 2005;105(2):906-7.
2005: Gunnar Cario; Martin Stanulla; Bernard M Fine; Oliver Teuffel; Nils von neuhoff; André Schrauder; Thomas Flohr; Beat W Schäfer; Claus R Bartram; Karl Welte; Brigitte Schlegelberger; Martin Schrappe
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.
Blood 2005;105(2):821-6.
2005: Martin Stanulla; Elke Schäffeler; Stefan Arens; Anke Rathmann; André Schrauder; Karl Welte; Michel Eichelbaum; Uli Zanger; Martin Schrappe; Matthias Schwab
GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia.
International journal of hematology 2005;81(1):39-44.
2005: T Cloppenborg; M Stanulla; Martin Zimmermann; Martin Schrappe; Karl Welte; Christoph Klein
Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups.
Leukemia 2005;19(1):44-8.
2004: Thorben Kracht; Martin Schrappe; Sabine Strehl; Alfred Reiter; Holger-Andreas Elsner; Jan Trka; Gunnar Cario; Susanne Viehmann; Jochen Harbott; Arndt Borkhardt; Markus Metzler; Thorsten Langer; Roland Repp; Rolf Marschalek; Karl Welte; Oskar A Haas; Martin Stanulla
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Haematologica 2004;89(12):1492-7.
2004: Barbara Meissner; Martin Stanulla; Wolf-Dieter Ludwig; Jochen Harbott; Anja Möricke; Karl Welte; Martin Schrappe
The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia.
Leukemia 2004;18(11):1920-3.
2004: Markus Metzler; Pamela L Strissel; Reiner Strick; Charlotte Niemeyer; Silja Roettgers; Arndt Borkhardt; Jochen Harbott; Wolf D Ludwig; Martin Stanulla; Martin Schrappe; Dirk Reinhardt; Ursula Creutzig; Jörn D Beck; Wolfgang Rascher; Roland Repp; Thorsten Langer
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2004;41(3):291-6.
2004: Jan-Nicolas Machatschek; André Schrauder; Frank Helm; Martin Schrappe; Alexander Claviez
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literature.
Pediatric hematology and oncology 2004;21(7):621-6.
2004: Tim Eden; Ching-Hon Pui; Martin Schrappe; Gianni Tognoni; Giuseppe Masera
All children have a right to full access to treatment for cancer.
Lancet 2004;364(9440):1121-2.
2004: Thorsten Simon; Barbara Hero; Andreas Faldum; Rupert Handgretinger; Martin Schrappe; Dietrich Niethammer; Frank Berthold
Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3549-57.
2004: Giuseppe Masera; Tim Eden; Martin Schrappe; James B Nachman; Helmut Gadner; Paul S Gaynon; William Evans; Ching-Hon Pui
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia.
Pediatric blood & cancer 2004;43(2):103-4.
2004: Oliver Teuffel; Michael Dettling; Gunnar Cario; Martin Stanulla; Martin Schrappe; Peter Bühlmann; Felix K Niggli; Beat W Schäfer
Gene expression profiles and risk stratification in childhood acute lymphoblastic leukemia.
Haematologica 2004;89(7):801-8.
2004: Peter Bader; Hermann Kreyenberg; Walter Hoelle; Gregor Dueckers; Rupert Handgretinger; Peter Lang; Bernhard Kremens; Dagmar Dilloo; Karl-Walter Sykora; Martin Schrappe; Charlotte Niemeyer; Arend von Stackelberg; Bernd Gruhn; Günter Henze; Johann Greil; Dietrich Niethammer; Klaus Dietz; James F Beck; Thomas Klingebiel
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
2004: Nyla A Heerema; Jochen Harbott; S Galimberti; Bruce M Camitta; Paul S Gaynon; Gritta E Janka-Schaub; W Kamps; G Basso; Ching-Hon Pui; Martin Schrappe; M-F Auclerc; Andrew J Carroll; Valentino Conter; Christine J Harrison; Jeanette Pullen; Susana C Raimondi; S Richards; Hansjörg Riehm; Harland Sather; Jonathan J Shuster; Lewis B Silverman; M G Valsecchi; M Aricò
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia 2004;18(4):693-702.
2004: Bernard M Fine; Martin Stanulla; Martin Schrappe; Minh Ho; Susanne Viehmann; Jochen Harbott; Linda M Boxer
Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.
Blood 2004;103(3):1043-9.
2004: Ching-Hon Pui; Martin Schrappe; Raul C Ribeiro; Charlotte M Niemeyer
Childhood and adolescent lymphoid and myeloid leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():118-45.
2004: Martin Schrappe
Evolution of BFM trials for childhood ALL.
Annals of hematology 2004;83 Suppl 1():S121-3.
2004: Markus Metzler; U Brehm; Thorsten Langer; Susanne Viehmann; Arndt Borkhardt; Martin Stanulla; Martin Schrappe; Jochen Harbott; Jörn D Beck; Wolfgang Rascher; Roland Repp
Asymmetric multiplex-polymerase chain reaction - a high throughput method for detection and sequencing genomic fusion sites in t(4;11).
British journal of haematology 2004;124(1):47-54.
2003: Lorenz Grigull; R Beier; André Schrauder; Philip Kirschner; L Loening; T Jack; Karl Welte; Karl-Walter Sykora; Martin Schrappe
Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL.
Mycoses 2003;46(11-12):441-6.
2003: Melchior Lauten; Gunnar Cario; Girmay Asgedom; Karl Welte; Martin Schrappe
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
Haematologica 2003;88(11):1253-8.
2003: Martin Schrappe
Prognostic factors in childhood acute lymphoblastic leukemia.
Indian journal of pediatrics 2003;70(10):817-24.
2003: Melchior Lauten; Carmela Beger; K Gerdes; Girmay Asgedom; Christian Kardinal; Karl Welte; Martin Schrappe
Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
Leukemia 2003;17(8):1551-6.
2003: Frank Berthold; Barbara Hero; Bernhard Kremens; R Handgretinger; Günter Henze; Freimut H Schilling; Martin Schrappe; Thorsten Simon; Claudia Spix
Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.
Cancer letters 2003;197(1-2):11-7.
2003: Carmela Beger; Katrin Gerdes; Melchior Lauten; Wim J E Tissing; Ivonne Fernandez-Munoz; Martin Schrappe; Karl Welte
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach.
British journal of haematology 2003;122(2):245-52.
2003: Hassan Jumaa; Lukas Bossaller; Karina Portugal; Bettina Storch; Michael Lotz; Alexandra Flemming; Martin Schrappe; Ville Postila; Pekka Riikonen; Jukka Pelkonen; Charlotte M Niemeyer; Michael Reth
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
Nature 2003;423(6938):452-6.
2003: Kathrin Seidemann; Markus Tiemann; I Lauterbach; Georg Mann; I Simonitsch; K Stankewitz; Martin Schrappe; Martin Zimmermann; Charlotte Niemeyer; Reza Parwaresch; Hansjörg Riehm; Alfred Reiter
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1782-9.
2003: Thorsten Langer; Markus Metzler; Dirk Reinhardt; Susanne Viehmann; Arndt Borkhardt; Martin Reichel; Martin Stanulla; Martin Schrappe; Ursula Creutzig; Jörg Ritter; Thomas Leis; Ulla Jacobs; Jochen Harbott; Jörn D Beck; Wolfgang Rascher; Roland Repp
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Genes, chromosomes & cancer 2003;36(4):393-401.
2003: Melchior Lauten; Girmay Asgedom; Karl Welte; Martin Schrappe; Martin Stanulla
Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Haematologica 2003;88(3):353-4.
2003: Wilhelm Wössmann; Martin Schrappe; Ulrike Meyer; Martin Zimmermann; Alfred Reiter
Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Annals of hematology 2003;82(3):160-5.
2003: Steven W Warmann; Jörg Fuchs; Natalie K Jesch; Martin Schrappe; Benno M Ure
A prospective study of minimally invasive techniques in pediatric surgical oncology: preliminary report.
Medical and pediatric oncology 2003;40(3):155-7.
2003: Britta Bürger; Martin Zimmermann; Georg Mann; Joachim Kühl; Lutz Löning; Hansjörg Riehm; Alfred Reiter; Martin Schrappe
Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):184-8.
2002: Martin Schrappe; Rita Beier; Britta Bürger
New treatment strategies in childhood acute lymphoblastic leukaemia.
Best practice & research. Clinical haematology 2002;15(4):729-40.
2002: Seisho Takeuchi; Naoko Takeuchi; Kunihiro Tsukasaki; Claus R Bartram; Martin Zimmermann; Martin Schrappe; Hirokuni Taguchi; H Phillip Koeffler
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia.
British journal of haematology 2002;119(4):985-7.
2002: Andishe Attarbaschi; Georg Mann; Michael Dworzak; Peter Wiesbauer; Martin Schrappe; Helmut Gadner
Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response.
Medical and pediatric oncology 2002;39(6):558-65.
2002: Arndt Borkhardt; Christian Wuchter; Susanne Viehmann; Sabine Pils; Andrea Teigler-Schlegel; Martin Stanulla; M Zimmermann; Wolf-Dieter Ludwig; Gritta E Janka-Schaub; Martin Schrappe; Jochen Harbott
Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
Leukemia 2002;16(9):1685-90.
2002: Melchior Lauten; Torsten Matthias; Martin Stanulla; Carmela Beger; Karl Welte; Martin Schrappe
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Leukemia 2002;16(8):1437-42.
2002: Björn-Ole Dieckvoss; Martin Stanulla; Martin Schrappe; Rita Beier; Martin Zimmermann; Karl Welte; Alfred Reiter
Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma.
Haematologica 2002;87(7):709-13; discussion 713.
2002: Marja J Willemse; Taku Seriu; Klaudia Hettinger; Elisabetta d'Aniello; Wim C J Hop; E Renate Panzer-Grümayer; Andrea Biondi; Martin Schrappe; Willem A Kamps; Guiseppe Masera; Helmut Gadner; Hansjörg Riehm; Claus R Bartram; Jacques J M van Dongen
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.
Blood 2002;99(12):4386-93.
2002: Ching-Hon Pui; Paul S Gaynon; James M Boyett; Judith M Chessells; André Baruchel; Willem Kamps; Lewis B Silverman; Andrea Biondi; Dieter Harms; Etienne Vilmer; Martin Schrappe; Bruce M Camitta
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Lancet 2002;359(9321):1909-15.
2002: Christian Wuchter; Velia Ruppert; Martin Schrappe; Bernd Dörken; Wolf-Dieter Ludwig; Leonid Karawajew
In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
Blood 2002;99(11):4109-15.
2002: Hans-Joachim Müller; Rita Beier; João Casimiro da Palma; Claudia Lanvers; Elvira Ahlke; Volker von Schütz; Martin Gunkel; Alexander Horn; Martin Schrappe; Günter Henze; Karen Kranz; Joachim Boos
PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.
Cancer chemotherapy and pharmacology 2002;49(2):149-54.
2002: Oliver A Cornely; Ullrich Bethe; Harald Seifert; Kai Breuer; H Schütt-Gerowitt; Bernd Salzberger; Martin Schrappe; Gerd Fätkenheuer
A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
Annals of hematology 2002;81(1):37-43.
2001: Hans-Joachim Müller; Rita Beier; L Löning; R Blütters-Sawatzki; Wolfgang Dörffel; E Maass; ST Müller-Weihrich; Hans G Scheel-Walter; F Scherer; Karsten Stahnke; Martin Schrappe; Alexander Horn; K Lümkemann; Joachim Boos
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment.
British journal of haematology 2001;114(4):794-9.
2001: Cornelio Uderzo; Adriana Balduzzi; Paola de Lorenzo; Maria Grazia Valsecchi; Helmut Gadner; T Klingebiel; M Zimmermann; Martin Schrappe
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (VHR) childhood acute lymphoblastic leukaemia in first complete remission.
Bone marrow transplantation 2001;28 Suppl 1():S22-4.
2001: Melchior Lauten; Martin Stanulla; Martin Zimmermann; Karl Welte; Hansjörg Riehm; Martin Schrappe
Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter.
Klinische Pädiatrie 2001;213(4):169-74.
2001: Kathrin Seidemann; Markus Tiemann; Martin Schrappe; E Yakisan; I Simonitsch; Gritta E Janka-Schaub; Wolfgang Dörffel; Martin Zimmermann; Georg Mann; Helmut Gadner; Reza Parwaresch; Hansjörg Riehm; Alfred Reiter
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 2001;97(12):3699-706.
2001: Oliver A Cornely; Ullrich Bethe; Bernd Salzberger; Caspar Franzen; Pia Hartmann; T Steinmetz; Gerd Fätkenheuer; Harald Seifert; Volker Diehl; Martin Schrappe
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
Annals of hematology 2001;80(2):103-8.
2001: Udo zur Stadt; Dieter Harms; S Schlüter; Martin Schrappe; U Goebel; Hans J Spaar; Gritta Janka; Hartmut Kabisch
MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.
Leukemia 2001;15(2):283-5.
2001: Karl Seeger; Susanne Viehmann; D Buchwald; Jochen Harbott; Martin Schrappe; Jan Stary; Günter Henze; Jan Trka
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL.
Leukemia 2001;15(2):280-2.
2001: I Scholz; Susanne Popp; Martin Granzow; Brigitte Schoell; Heidi Holtgreve-Grez; S Takeuchi; Martin Schrappe; Jochen Harbott; Andrea Teigler-Schlegel; M Zimmermann; Christine Fischer; H P Koeffler; Claus R Bartram; Anna Jauch
Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis.
Cancer genetics and cytogenetics 2001;124(2):89-97.
2001: J Grenzebach; Martin Schrappe; Wolf-Dieter Ludwig; Reza Parwaresch; Martin Zimmermann; Helmut Gadner; Hansjörg Riehm; Alfred Reiter
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
Annals of hematology 2001;80 Suppl 3():B73-6.
2000: Martin Schrappe; Alfred Reiter; Martin Zimmermann; Jochen Harbott; Wolf-Dieter Ludwig; Günter Henze; Helmut Gadner; E Odenwald; Hansjörg Riehm
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Leukemia 2000;14(12):2205-22.
2000: Martin Schrappe; B Camitta; Ching-Hon Pui; T Eden; P Gaynon; G Gustafsson; Gritta E Janka-Schaub; W Kamps; Giuseppe Masera; Stephen E Sallan; M Tsuchida; E Vilmer
Long-term results of large prospective trials in childhood acute lymphoblastic leukemia.
Leukemia 2000;14(12):2193-4.
2000: G Anderer; Martin Schrappe; A M Brechlin; Melchior Lauten; P Muti; Karl Welte; Martin Stanulla
Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
Pharmacogenetics 2000;10(8):715-26.
2000: Andrea Biondi; M G Valsecchi; Taku Seriu; Elisabetta d'Aniello; Marja J Willemse; Karin Fasching; A Pannunzio; Helmut Gadner; Martin Schrappe; Willem A Kamps; Claus R Bartram; Jacques J M van Dongen; E Renate Panzer-Grümayer
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.
Leukemia 2000;14(11):1939-43.
2000: Hans-Joachim Müller; L Löning; Alexander Horn; D Schwabe; Martin Gunkel; Martin Schrappe; Volker von Schütz; Günter Henze; J Casimiro da Palma; J Ritter; J P Pinheiro; M Winkelhorst; Joachim Boos
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.
British journal of haematology 2000;110(2):379-84.
2000: Udo zur Stadt; Dieter Harms; S Schlüter; Norbert Jorch; Hans J Spaar; W Nürnberger; S Völpel; P Gutjahr; Martin Schrappe; Gritta Janka; Hartmut Kabisch
[Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
Klinische Pädiatrie 2000;212(4):169-73.
2000: Christian Wuchter; Leonid Karawajew; Velia Ruppert; Martin Schrappe; Jochen Harbott; Richard Ratei; Bernd Dörken; Wolf-Dieter Ludwig
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;110(1):154-60.
2000: Christian Wuchter; K Leonid; Velia Ruppert; Martin Schrappe; Thomas Büchner; Claudia Schoch; Torsten Haferlach; Jochen Harbott; Richard Ratei; Bernd Dörken; Wolf-Dieter Ludwig
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Haematologica 2000;85(7):711-21.
2000: Leonid Karawajew; Velia Ruppert; Christian Wuchter; A Kösser; Martin Schrappe; Bernd Dörken; Wolf-Dieter Ludwig
Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Blood 2000;96(1):297-306.
2000: Martin Schrappe; Alfred Reiter; Wolf-Dieter Ludwig; Jochen Harbott; Martin Zimmermann; Wolfgang Hiddemann; Charlotte Niemeyer; Günter Henze; A Feldges; Felix Zintl; Bernhard Kornhuber; Jörg Ritter; Karl Welte; Helmut Gadner; Hansjörg Riehm
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Blood 2000;95(11):3310-22.
2000: L Löning; Martin Zimmermann; Alfred Reiter; Peter Kaatsch; Günter Henze; Hansjörg Riehm; Martin Schrappe
Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.
Blood 2000;95(9):2770-5.
2000: Martin Stanulla; M Stümm; B O Dieckvoss; Kathrin Seidemann; V Schemmel; A Müller Brechlin; Martin Schrappe; Karl Welte; Alfred Reiter
No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence.
British journal of haematology 2000;109(1):117-20.
2000: Martin Stanulla; Martin Schrappe; A M Brechlin; Martin Zimmermann; Karl Welte
Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study.
Blood 2000;95(4):1222-8.
2000: Martin Stanulla; Brigitte Kasper; Martin Schrappe; Susanne Viehmann; Jochen Harbott; Wolf-Dieter Ludwig; Karl Welte
Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life.
Leukemia 2000;14(2):337-8.
2000: Alfred Reiter; Martin Schrappe; Wolf-Dieter Ludwig; Markus Tiemann; Reza Parwaresch; Martin Zimmermann; E Schirg; Günter Henze; Günther Schellong; Helmut Gadner; Hansjörg Riehm
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood 2000;95(2):416-21.
2000: Oliver A Cornely; Bernd Salzberger; Ullrich Bethe; Harald Seifert; Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Antibiotics and chemotherapy 2000;50():37-46.
1999: Seisho Takeuchi; S K Cho; Taku Seriu; M Koike; Claus R Bartram; A Reiter; Martin Schrappe; C Takeuchi; Hirokuni Taguchi; H Phillip Koeffler
Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia.
Oncogene 1999;18(51):7387-8.
1999: Alfred Reiter; Martin Schrappe; Markus Tiemann; Wolf-Dieter Ludwig; E Yakisan; Martin Zimmermann; Georg Mann; A Chott; Wolfram Ebell; Thomas Klingebiel; Norbert Graf; Bernhard Kremens; S Müller-Weihrich; H J Plüss; Felix Zintl; Günter Henze; Hansjörg Riehm
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 1999;94(10):3294-306.
1999: Michael Dördelmann; Alfred Reiter; Arndt Borkhardt; Wolf-Dieter Ludwig; N Götz; Susanne Viehmann; Helmut Gadner; Hansjörg Riehm; Martin Schrappe
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
Blood 1999;94(4):1209-17.
1999: Ulrike B Graubner; Joachim Boos; Ursula Creutzig; Wolfgang Dörffel; M Lakomek; Charlotte Niemeyer; Martin Schrappe; Hans J Spaar; Bernd H Belohradsky
[Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)].
Klinische Pädiatrie 1999;211(4):347-52.
1999: Andreas Müller; K Stellermann; Pia Hartmann; Martin Schrappe; Gerd Fätkenheuer; Bernd Salzberger; Volker Diehl; Caspar Franzen
A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens.
Clinical and diagnostic laboratory immunology 1999;6(2):243-6.
1999: Joao Paulo Vieira Pinheiro; Elvira Ahlke; Ulrike Nowak-Göttl; Georg Hempel; Hans-Joachim Müller; K Lümkemann; Martin Schrappe; B Rath; Gudrun Fleischhack; G Mann; Joachim Boos
Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols.
British journal of haematology 1999;104(2):313-20.
1998: Jacques J M van Dongen; Taku Seriu; E Renate Panzer-Grümayer; Andrea Biondi; MJ Pongers-Willemse; L Corral; F Stolz; Martin Schrappe; Guiseppe Masera; Willem A Kamps; Helmut Gadner; Elisabeth R van Wering; W D Ludwig; G Basso; MA de Bruijn; Giovanni Cazzaniga; Klaudia Hettinger; Anna van der Does-van den Berg; Wim C J Hop; Hansjörg Riehm; Claus R Bartram
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
Lancet 1998;352(9142):1731-8.
1998: Martin Schrappe; M Aricò; Jochen Harbott; A Biondi; Martin Zimmermann; Valentino Conter; Alfred Reiter; M G Valsecchi; Helmut Gadner; G Basso; Claus R Bartram; Fritz H Lampert; Hansjörg Riehm; G Masera
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
Blood 1998;92(8):2730-41.
1998: Richard Ratei; C Sperling; Leonid Karawajew; G Schott; Martin Schrappe; Jochen Harbott; Hansjörg Riehm; Wolf-Dieter Ludwig
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Annals of hematology 1998;77(3):107-14.
1998: Michael Dördelmann; Alfred Reiter; Martin Zimmermann; R Fengler; Günter Henze; Hansjörg Riehm; Martin Schrappe
Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology 1998;20(5):444-50.
1998: Kathrin Seidemann; Ulrike Meyer; P Jansen; E Yakisan; K Rieske; Monika Führer; Bernhard Kremens; Martin Schrappe; Alfred Reiter
Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials.
Klinische Pädiatrie 1998;210(4):279-84.
1998: Martin Schrappe; Alfred Reiter; Günter Henze; Charlotte Niemeyer; Udo Bode; Joachim Kühl; Helmut Gadner; W Havers; H Plüss; Bernhard Kornhuber; Felix Zintl; Jörg Ritter; C Urban; Dietrich Niethammer; Hansjörg Riehm
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Klinische Pädiatrie 1998;210(4):192-9.
1998: Seisho Takeuchi; M Koike; Taku Seriu; Claus R Bartram; Martin Schrappe; A Reiter; S Park; HE Taub; I Kubonishi; I Miyoshi; H Phillip Koeffler
Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia.
Cancer research 1998;58(12):2618-23.
1998: Martin Schrappe; Alfred Reiter; Hansjörg Riehm
Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia.
Journal of neuro-oncology 1998;38(2-3):159-65.
1998: G Schott; C Sperling; Martin Schrappe; Richard Ratei; M Martin; U Meyer; Hansjörg Riehm; Wolf-Dieter Ludwig
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
British journal of haematology 1998;101(4):753-5.
1998: Michael Dördelmann; Martin Schrappe; Alfred Reiter; Martin Zimmermann; Norbert Graf; G Schott; Fritz H Lampert; Jochen Harbott; Charlotte Niemeyer; J Ritter; Wolfgang Dörffel; G Nessler; Joachim Kühl; Hansjörg Riehm
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
Leukemia 1998;12(5):645-51.
1998: Andreas Müller; Gerd Fätkenheuer; Bernd Salzberger; Martin Schrappe; Volker Diehl; Caspar Franzen
[Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma].
Deutsche medizinische Wochenschrift (1946) 1998;123(13):381-5.
1998: J Ritterbach; W Hiddemann; J D Beck; Martin Schrappe; G Janka-Schaub; Wolf-Dieter Ludwig; Jochen Harbott; Fritz H Lampert
Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Leukemia 1998;12(3):427-33.
1998: Karl Seeger; H P Adams; D Buchwald; B Beyermann; Bernhard Kremens; Charlotte Niemeyer; J Ritter; D Schwabe; D Harms; Martin Schrappe; Günter Henze
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
Blood 1998;91(5):1716-22.
1998: Caspar Franzen; Andreas Müller; Pia Hartmann; P Hegener; Martin Schrappe; Volker Diehl; Gerd Fätkenheuer; Bernd Salzberger
Polymerase chain reaction for diagnosis and species differentiation of microsporidia.
Folia parasitologica 1998;45(2):140-8.
1997: Gerd Fätkenheuer; Caspar Franzen; Pia Hartmann; Klaus Wassermann; Martin Schrappe; W Dölken; Volker Diehl; Bernd Salzberger
[Cystic form of Pneumocystis carinii pneumonia].
Deutsche medizinische Wochenschrift (1946) 1997;122(47):1441-6.
1997: Valentino Conter; Martin Schrappe; M Aricó; Alfred Reiter; Carmelo Rizzari; Michael Dördelmann; Maria Grazia Valsecchi; Martin Zimmermann; Wolf-Dieter Ludwig; Giuseppe Basso; Giuseppe Masera; Hansjörg Riehm
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2786-91.
1997: Arndt Borkhardt; Giovanni Cazzaniga; Susanne Viehmann; M G Valsecchi; Wolf-Dieter Ludwig; L Burci; S Mangioni; Martin Schrappe; Hansjörg Riehm; Fritz H Lampert; G Basso; G Masera; Jochen Harbott; A Biondi
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
Blood 1997;90(2):571-7.
1997: M Mielcarek; C Sperling; Martin Schrappe; U Meyer; Hansjörg Riehm; Wolf-Dieter Ludwig
Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome.
British journal of haematology 1997;96(2):301-7.
1996: C Bührer; R Hartmann; R Fengler; B Rath; Martin Schrappe; Gritta E Janka-Schaub; Günter Henze
Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2812-7.
1996: Achim Schwenk; E Höffer-Belitz; B Jung; Gisela Kremer; B Bürger; Bernd Salzberger; Volker Diehl; Martin Schrappe
Resting energy expenditure, weight loss, and altered body composition in HIV infection.
Nutrition (Burbank, Los Angeles County, Calif.) 1996;12(9):595-601.
1996: S Schlieben; Arndt Borkhardt; I Reinisch; J Ritterbach; Johannes W G Janssen; Richard Ratei; Martin Schrappe; Roland Repp; Martin Zimmermann; Hartmut Kabisch; Gritta E Janka-Schaub; C R Bartram; Wolf-Dieter Ludwig; Hansjörg Riehm; Fritz H Lampert; Jochen Harbott
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Leukemia 1996;10(6):957-63.
1996: Caspar Franzen; Andreas Müller; Volker Diehl; Martin Schrappe
[Microsporidia--biology and clinical relevance].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(5):284-94.
1996: Seisho Takeuchi; Claus R Bartram; Carl W Miller; A Reiter; Taku Seriu; M Zimmerann; Martin Schrappe; N Mori; J Slater; I Miyoshi; H Phillip Koeffler
Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1.
Blood 1996;87(8):3368-74.
1996: Karl Welte; Alfred Reiter; K Mempel; M Pfetsch; G Schwab; Martin Schrappe; Hansjörg Riehm
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Blood 1996;87(8):3143-50.
1996: Martin Schrappe
[Clinical infectiology--I. Diagnosis, pathogen spectrum and resistance].
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 1():166-75.
1996: Caspar Franzen; R Kuppers; A Muller; Bernd Salzberger; G Fatkenheuer; B Vetten; Volker Diehl; Martin Schrappe
Genetic evidence for latent Septata intestinalis infection in human immunodeficiency virus-infected patients with intestinal microsporidiosis.
The Journal of infectious diseases 1996;173(4):1038-40.
1996: Bernd Salzberger; Caspar Franzen; Gerd Fätkenheuer; Oliver A Cornely; Achim Schwenk; H Rasokat; Volker Diehl; Martin Schrappe
CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(4):365-9.
1996: Bernd Salzberger; Albrecht Stoehr; H Jablonowski; Walter Heise; U Ewald; K Peters; Gerd Fätkenheuer; Martin Schrappe
Foscarnet 5 versus 7 days a week treatment for severe gastrointestinal CMV disease in HIV-infected patients.
Infection 1996;24(2):121-4.
1995: Caspar Franzen; Andreas Müller; Achim Schwenk; Bernd Salzberger; Gerd Fätkenheuer; G Mahrle; Volker Diehl; Martin Schrappe
Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS--response to albendazole.
The Journal of infection 1995;31(3):237-9.
1995: Caspar Franzen; Andreas Müller; Bernd Salzberger; Gerd Fätkenheuer; S Eidt; G Mahrle; Volker Diehl; Martin Schrappe
Tissue diagnosis of intestinal microsporidiosis using a fluorescent stain with Uvitex 2B.
Journal of clinical pathology 1995;48(11):1009-10.
1995: Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
[Clinical aspects and therapy of ubiquitous mycobacterioses].
Der Internist 1995;36(10):987-94.
1995: Caspar Franzen; Andreas Müller; P Hegener; Bernd Salzberger; Pia Hartmann; Gerd Fätkenheuer; Volker Diehl; Martin Schrappe
Detection of microsporidia (Enterocytozoon bieneusi) in intestinal biopsy specimens from human immunodeficiency virus-infected patients by PCR.
Journal of clinical microbiology 1995;33(9):2294-6.
1995: Caspar Franzen; Bernd Salzberger; Gerd Fätkenheuer; D Ziegenhagen; Oliver A Cornely; Volker Diehl; Martin Schrappe
Stimulated duodenal/bile juice aspiration for diagnosis of enteric pathogens in HIV-infected patients.
Journal of clinical gastroenterology 1995;21(1):33-7.
1995: H Jablonowski; Keikawus Arastéh; Schlomo Staszewski; B Ruf; Hans-Jürgen Stellbrink; Martin Schrappe; Albrecht Stoehr; W Haase; U Schomaker; B von Eisenhart Rothe
A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.
AIDS (London, England) 1995;9(5):463-9.
1995: Alfred Reiter; Martin Schrappe; R Parwaresch; Günter Henze; S Müller-Weihrich; S Sauter; Karl-Walter Sykora; Wolf-Dieter Ludwig; Helmut Gadner; Hansjörg Riehm
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):359-72.
1995: Martin Schrappe; Bernd Salzberger
[Fever in immunosuppressed patients].
Der Internist 1995;36(2):162-9.
1994: Martin Schrappe
[Clinical infectiology update. I: Diagnosis, pathogen spectrum and resistance].
Medizinische Klinik (Munich, Germany : 1983) 1994;89(12):652-61.
1994: Bernd Salzberger; Martin Schrappe; Volker Diehl
[Antiretroviral therapy in adult HIV-infected patients].
Der Internist 1994;35(12):1095-104.
1994: B Bürger; Achim Schwenk; H Jünger; G Ollenschläger; D Wessel; Volker Diehl; Martin Schrappe
Oral supplements in HIV-infected patients with chronic wasting. A prospective trial.
Medizinische Klinik (Munich, Germany : 1983) 1994;89(11):579-81, 633.
1994: Alfred Reiter; Martin Schrappe; Wolf-Dieter Ludwig; Wolfgang Hiddemann; S Sauter; Günter Henze; Martin Zimmermann; F Lampert; W Havers; Dietrich Niethammer
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
Blood 1994;84(9):3122-33.
1994: Caspar Franzen; Gerd Fätkenheuer; Bernd Salzberger; Andreas Müller; G Mahrle; Volker Diehl; Martin Schrappe
Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome--report of three more German cases.
Infection 1994;22(6):417-9.
1994: S H Schmitz; S Scheding; Dimitris Voliotis; H Rasokat; Volker Diehl; Martin Schrappe
Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood.
Annals of hematology 1994;69(3):135-8.
1994: Alfred Reiter; Martin Schrappe; E Yakisan; S Sauter; Wolfram Ebell; Martin Zimmermann; W Hartmann; Bernhard Kremens; N Kuhn; A Claviez
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
Klinische Pädiatrie 1994;206(4):242-52.
1994: Alfred Reiter; Martin Schrappe; E Yakisan; S Sauter; Dietrich Henzler; Martin Zimmermann; Norbert Graf; R Fengler; J Kühl; Gudrun Fleischhack
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2: An intermediate term analysis of the non-B-NHL therapy group. BFM Study group].
Klinische Pädiatrie 1994;206(4):234-41.
1994: Alfred Reiter; Markus Tiemann; Wolf-Dieter Ludwig; H H Wacker; E Yakisan; Martin Schrappe; Dietrich Henzler; Karl-Walter Sykora; A Brandt; E Odenwald
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
Klinische Pädiatrie 1994;206(4):222-33.
1994: Alfred Reiter; Martin Schrappe; Markus Tiemann; R Parwaresch; Martin Zimmermann; E Yakisan; R Dopfer; P Bucsky; Georg Mann; Helmut Gadner
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):899-908.
1994: Bernd Salzberger; Albrecht Stoehr; Walter Heise; Gerd Fätkenheuer; Achim Schwenk; Caspar Franzen; Oliver A Cornely; Martin Schrappe
Foscarnet and ganciclovir combination therapy for CMV disease in HIV-infected patients.
Infection 1994;22(3):197-200.
1993: Achim Schwenk; B Büger; D Wessel; Hartmut Stützer; D Ziegenhagen; Volker Diehl; Martin Schrappe
Clinical risk factors for malnutrition in HIV-1-infected patients.
AIDS (London, England) 1993;7(9):1213-9.
1993: Caspar Franzen; Gerd Fätkenheuer; Bernd Salzberger; D Ziegenhagen; H M Seitz; Volker Diehl; Martin Schrappe
[Isospora belli infection in an AIDS patient].
Medizinische Klinik (Munich, Germany : 1983) 1993;88(5):330-2.
1993: B Bürger; G Ollenschläger; Martin Schrappe; A Stute; M Fischer; D Wessel; Achim Schwenk; Volker Diehl
Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention.
Nutrition (Burbank, Los Angeles County, Calif.) 1993;9(1):43-4.
1992: Alfred Reiter; Martin Schrappe; Wolf-Dieter Ludwig; F Lampert; Jochen Harbott; Günter Henze; C M Niemeyer; Helmut Gadner; S Müller-Weihrich; J Ritter
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Blood 1992;80(10):2471-8.
1992: Caspar Franzen; Bernd Salzberger; Gerd Fätkenheuer; S Eidt; Martin Schrappe
[Mucosa-associated immune system in HIV-1 infection. T-cell subpopulations compared in different segments of the gastrointestinal tract].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(10):510-2, 549.
1992: Martin Schrappe; Klaus Wassermann; D Ziegenhagen; Bernd Salzberger; Gerd Fätkenheuer; Achim Schwenk; A Hiersche; Volker Diehl
[Pneumocystis carinii in oncologic diseases].
Medizinische Klinik (Munich, Germany : 1983) 1992;87 Suppl 1():65-70.
1991: Martin Schrappe; C Pohl; Hans Tesch; Volker Diehl
[HIV-associated non-hodgkin lymphoma. Prognosis and therapeutic options].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(12):646-54, 660.
1987: Martin Schrappe; J Beck; W E Brandeis; H J Feickert; Helmut Gadner; Norbert Graf; W Havers; Günter Henze; A Jobke; Bernhard Kornhuber
[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81].
Klinische Pädiatrie 1987;199(3):133-50.